Cases | Number in group | Relevant stages | Comments |
---|---|---|---|
Control | 9 | AD (BNE/Braak) 0-II [11] | |
AD | 15 | AD (BNE/Braak) IV-VI | 2 cases mild cortical TDP-43 |
PSP | 3 | ||
CBD | 5 Total = 7 | ||
MAPT (with CBD pathology) | 2 | ||
DLB | 5 | Limbic [10] - 3 | |
Neocortical - 2 | |||
MSA | 3 | ||
HD | 6 | ||
FTLD-TDP/FTLD-MND | 6 | FTLD-TDP -1 | 1 case C9orf72 mutation |
FTLD-MND -5 | |||
Metabolic disease | 1 | Batten’s disease | CLN2 mutation |
Cerebrovascular disease | 1 | Infarct and amyloid angiopathy | |
ALS | 2 | No extramotor inclusions | |
Combined AD and DLB | 4 | AD (BNE Braak) (V-VI) | 1 case mild cortical TDP-43 |
DLB Limbic -2 | |||
DLB Neocortical - 2 |